The American Journal of Drug and Alcohol Abuse This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research

Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder
Conclusions: This study provides preliminary evidence supporting the feasibility of inducting individuals with OUD onto ER-NTX using lofexidine.PMID:37791817 | DOI:10.1080/00952990.2023.2241981 (Source: The American Journal of Drug and Alcohol Abuse)
Source: The American Journal of Drug and Alcohol Abuse - October 4, 2023 Category: Addiction Authors: John J Mariani Cale Basaraba Martina Pavlicova Daniel M Alschuler Daniel J Brooks Amy L Mahony Christina Brezing Nasir H Naqvi Frances R Levin Source Type: research